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Abstract 
Objective: This study aims to evaluate DAMA in PCI and how it affects readmissions. 
Background: Discharge against medical advice (DAMA) is infrequent but associated with 
poor patient outcomes.  DAMA in the context of PCI has not been described in the literature. 
Methods: We analysed patients in the Nationwide Readmission Database between 2010-
2014 with a PCI procedure who were either discharged home or against medical advice. The 
primary endpoint was all-cause 30-day readmissions and their causes. Descriptive statistics 
were used to compare DAMA with patients discharged home and multiple logistic 
regressions were used to determine patient characteristics associated with DAMA and 
readmission. 
Results: Among the 2,021,104 patients in the analysis, the proportion of patients who 
DAMA was 0.5% (n=10,049).  The 30-day readmission rate for patients who DAMA and 
those discharged home was 16.8% and 8.5% respectively (p<0.001).  Important predictors of 
DAMA included diagnosis of acute myocardial infarction (OR 1.37, 1.25-1.51, p<0.001), 
smoking (OR 1.71, 1.57-1.86, p<0.001), drug abuse (OR 1.82, 1.60-2.06, p<0.001) and 
alcohol misuse (OR 1.53, 1.32-1.78, p<0.001). DAMA was the strongest predictor for 
readmission (OR 1.89, 1.71-2.08, p<0.001). DAMA patients were more likely to have 
neuropsychiatric reasons for non-cardiac causes of readmission (8.3% vs 2.4%) and acute 
myocardial infarction for cardiac causes of readmission (39.4% vs 19.5%) compared to 
patients discharged home. 
Conclusions: DAMA occurs in approximately 0.5% of patients following PCI and is strongly 
associated with readmission within 30 days. Interventions should be developed to reduce 
DAMA in high-risk groups and initiate interventions to avoid complications and readmission 
when it occurs. 
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Condensed abstract (100 words) 
Discharge against medical advice (DAMA) in the context of PCI has not been described in 
the literature. Among the 2,021,104 patients, the proportion of patients who DAMA was 
0.5% (n=10,049).  Important predictors of DAMA included diagnosis of acute myocardial 
infarction, smoking, and alcohol misuse. DAMA was the strongest predictor for readmission 
(OR 1.92, 1.74-2.12, p<0.001). DAMA patients were more likely to have neuropsychiatric 
reasons for non-cardiac causes of readmission and acute myocardial infarction for cardiac 
causes of readmission compared to patients discharged home. DAMA following PCI is rare 
but it is strongly associated with readmissions within 30 days.  
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List of abbreviations 
DAMA = discharge against medical advice 
PCI = percutaneous coronary intervention 
NRD = Nationwide Readmission Database 
AHRQ = Agency for Healthcare Research and Quality  
HCUP = Healthcare Cost and Utilization Project 
ICD-9 = International Classification of Disease – 9th Clinical Modification  
CCS = Clinical classification software (CCS) 
US = United States 
OR = odds ratio 
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Perspective 
What is known? 
Discharge against medical advice (DAMA) is associated with poor patient outcomes and 
DAMA in the context of PCI has not been described in the literature. 
What is new? 
Our analysis of 2,021,104 patients reveals that the proportion of patients who DAMA was 
0.5% and important predictors of DAMA included diagnosis of acute myocardial infarction, 
smoking, and alcohol misuse. DAMA was the strongest predictor for unplanned 30-day 
readmission (OR 1.89, 1.71-2.08, p<0.001) and DAMA patients were more likely to have 
neuropsychiatric reasons for non-cardiac causes of readmission and acute myocardial 
infarction for cardiac causes of readmission compared to patients discharged home.  
DAMA following PCI is rare but it is strongly associated with readmissions within 30 days. 
What is next? 
Interventions should be developed to reduce DAMA in high risk groups and initiate 
interventions to avoid complications and readmission when it occurs. 
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Introduction 
Discharge against medical advice (DAMA) refers to patients who leave the hospital 
before the treating physician’s recommendation for discharge. It poses a problem for 
physicians treating hospitalized patients and has been noted to occur in 1-2% of all medical 
admissions.1 Some groups within the general population such as those with mental health 
problems are more likely to DAMA.2 Other factors that predict DAMA include self-financing 
healthcare, having Medicaid insurance and being young and male.2 Since patients who 
DAMA have been shown to be at higher risk of adverse outcomes, it has been suggested that 
these patients should be targeted for post-discharge interventions.3 
Historically, the literature related to DAMA originated from cohorts with psychiatric 
illnesses4 and substance misuse.5 A variety of factors precipitate DAMA including problems 
related to their illness such as substance seeking behaviour or other factors such as financial 
problems, family pressure on returning home and dissatisfaction with the hospital routine and 
treatment.6 DAMA is commonly seen in emergency departments and is associated with 
higher likelihood of worse outcomes and medicolegal consequences.  There is a growing 
literature suggesting that patients with cardiac problems also choose to DAMA.7-9 No 
previous study has evaluated DAMA in patients who undergo percutaneous coronary 
intervention (PCI). In this study, we examine rates, trends and predictors of DAMA, and 
evaluate causes of and rates of readmission for patients who DAMA compared to those with 
discharge home in the Nationwide Readmission Database. 
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Methods 
A full description of the methods is available in the Supplementary Methods. 
Study design and participants 
 The Nationwide Readmission Database (NRD) is a publicly available database of all-
payer hospital inpatients stays, which is developed by the Agency for Healthcare Research 
and Quality (AHRQ) as a part of the Healthcare Cost and Utilization Project (HCUP) in the 
Unites States.  The data are drawn from 21 states that are geographically dispersed and 
accounts for approximately 49% of total US resident population and approximately 49% of 
hospitalizations. 
In the current study, we included men and women aged 18 years or older who 
underwent first PCI between 2010 and 2014 and were either DAMA or were discharged 
home.  First PCI was defined by first procedure of PCI within a calendar year.  DAMA was 
defined from the variable "DISPUNIFORM" which represents the disposition of patient at 
discharge. We excluded patients who died during their index admission for PCI, those who 
had an elective readmission and those who were not discharged home or against medical 
advice.    
Variables and outcomes 
 The data collected is described in the Supplementary Methods. We used International 
Classification of Disease – 9th Clinical Modification (ICD-9) and Clinical classification 
software (CCS) of diseases codes to determine comorbidities, in-hospital procedures and 
outcomes. The cost of clinical care was determined by the claims change multiplied by the 
cost-to-charge ratio. 30-day readmissions were defined as first rehospitalization after 
discharge within 30 days from admission for PCI.  The causes of readmissions were 
determined from the principle diagnosis based on CCS codes as outlined in Supplementary 
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Table 1. The primary endpoint was all-cause 30-day readmissions and reasons for 
readmissions.   
Statistical analysis 
Statistical analysis was performed using Stata 14.0 (College Station, Texas, USA).  A 
flow diagram was used to determine the proportion of patients at each stage of the analysis 
and those who were readmitted as well as those who died on readmission. Descriptive 
statistics were used to compare patients who were DAMA compared to those who were 
discharged home with further stratification depending on whether or not they were 
readmitted.  Statistical differences between groups for continuous variables were tested using 
the t-test and for categorical variables the Chi2 test.  For all analyses, the survey estimation 
commands were used (e.g. svy: logistic for multiple logistic regression), following the 
recommendations from AHRQ for analysis of survey data to account for the complex survey 
design of the NRD database. Multiple logistic regressions were used to determine 
independent variables associated with DAMA and 30-day readmission. We performed 
sensitivity analysis in the subgroup of patients where elective cases were excluded. The major 
cardiac and non-cardiac causes of readmission for the DAMA and discharged home groups 
are presented in tables. 
 
Results 
A total of 2,021,104 participants were included in the analysis after exclusion of 
patients who died after first PCI (n=49,913), had an elective readmission (n=26,290), or were 
discharged to other places of care (n=276,410), Figure 1. The overall proportion of patients 
who DAMA over the whole study period was 0.5% (n=10,049). Figure 2 illustrates the 
temporal trends for DAMA at the index PCI procedure, increasing from 0.44 in 2010 to 0.59 
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in 2014 (p<0.001 for trend). The 30-day readmission rate for patients who DAMA and those 
who were non-DAMA was 16.8% and 8.5% respectively. 
The participant characteristics and in-hospital outcomes for the index PCI admission 
for patients stratified by whether they DAMA are shown in Table 1. Patients who DAMA 
were younger (57.2 vs 63.7 years), less likely to be female (18.9% vs 30.6%), less likely to be 
admitted electively (8.2% vs 17.3%) and be in the lowest quartile of income (36.5% vs 
27.8%).  Those who DAMA were more likely to be admitted on a weekend (35.6% vs 28.8%) 
and receive Medicaid (19.8% vs 7.7%). Significant differences were observed for most 
comorbidities, as well as smoking (65.6% vs 42.7%, p<0.001), alcohol misuse (8.4% vs 
2.6%) and drug abuse (10.7% vs 2.1%, p<0.001). A longer LOS (3.2 vs 3.0 days) and cost of 
index PCI ($20,441 vs $19,732) was observed in patients who DAMA. 
Table 2 shows the patient variables according to 30-day readmission status stratified 
by DAMA status. Among patients who were not readmitted, patients who DAMA were more 
likely to be smokers (66.0% vs 42.8%), abuse alcohol (7.9% vs 2.6%), abuse drugs (10.3% vs 
2.0%), previous MI (19.5% vs 14.2%), previous PCI (25.6% vs 21.2%), chronic lung disease 
(20.9% vs 14.8%) and less likely to receive drug eluting stent (60.2% vs 76.3%). For patients 
who were readmitted, those who DAMA were more likely to be smokers (63.7% vs 41.4%), 
misuse alcohol (10.7% vs 2.8%), drug abuse (10.7% vs 2.8%), have chronic lung disease 
(28.0% vs 22.2%), fluid and electrolyte disorders (21.8% vs 14.8%) and less likely to receive 
a drug eluting stent (54.4% vs 70.9%). A greater proportion of DAMA patients were 
uninsured and from the lowest median household income irrespective of readmission status. 
Table 3 shows the readmissions outcomes for patients according to whether or not the patient 
DAMA.  DAMA was associated with greater death (3.2% vs 2.0%), in-hospital MACE (6.1% 
vs 2.4%) and discharge against medical advice in the readmission (13.9% vs 1.1%).  Similar 
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increases were observed for both in the whole cohort of patients undergoing PCI and the 
subgroup of patients who were admitted with a diagnosis of acute myocardial infarction.  
The predictors of DAMA are shown in Table 4. Predictors of DAMA included 
smoking (OR 1.71, 1.57-1.86), alcohol misuse (OR 1.53, 1.32-1.78), and dementia (OR 1.52, 
1.03-2.24), whilst female gender (OR 0.58, 0.53-0.63) and elective admissions (OR 0.66, 
0.57-0.76) were independently associated with reduced odds of DAMA. Among patients with 
acute myocardial infarction, the strongest predictor of DAMA was acute kidney injury (OR 
2.51, 1.53-4.13), although drug (OR 1.83, 1.57-2.13) and alcohol (OR 1.28, 1.07-1.53) abuse 
and smoking (OR 1.77, 1.59-1.97) remained independent predictors  of DAMA 
(Supplementary Table 2). 
Table 5 shows the independent predictors of 30-day readmission. DAMA was the 
strongest predictor of 30-day unplanned readmissions (OR 1.89, 1.71-2.08) for all patients 
and for patients with admission for acute myocardial infarction (OR 1.96, 1.73-2.22, 
Supplementary Table 2). 
The causes of unplanned 30-day readmissions were subsequently studied in patients 
who DAMA and those who were discharged home. Table 6 shows that the proportion of 
patients with non-cardiac readmissions was higher in patients who were discharged home 
(54.5% vs 45.5%) whilst the rates of cardiac and non-cardiac readmission were similar for the 
DAMA group (50.2% vs 49.8%). 
 Table 6 shows the most common non-cardiac and cardiac causes for readmission 
according to whether patients DAMA or non-DAMA. Non-specific chest pain was the 
commonest non-cardiac cause for readmission for both patients who DAMA and those 
discharge home (19.7% and 20.2% respectively). For non-cardiac readmissions, patients who 
DAMA were more likely to have neuropsychiatric causes for readmission 8.3% (4th most 
common cause of readmission) compared to those patients discharged home (2.4%, 10th most 
11 
 
common cause). The specific causes of psychiatric readmissions in the DAMA group was 
mainly due to depression, bipolar and mood disorders (43.3%) and paranoid schizophrenia, 
schizoaffective disorder and psychosis (16.7%) (Supplementary Table 3). In terms of cardiac 
readmissions, acute MI was the commonest diagnosis-code for both cohorts, although 
patients who DAMA were twice as likely to be readmitted with the diagnosis-code of acute 
MI (39.4% vs 19.5%) compared to those discharged home.  For patients presenting with 
acute myocardial infarction at their index admission, DAMA was associated with increase 
rates of cardiac readmissions (56.6% vs 49.2%) (Supplementary Table 2). Non-cardiac chest 
pain was the most common reason for non-cardiac readmissions. The most frequent reasons 
for cardiac readmission for both DAMA and not DAMA in the acute myocardial infarction 
groups were diagnosis of acute myocardial infarction and coronary artery disease including 
angina. 
 
Discussion 
DAMA is a rare occurrence among patients who undergo PCI and is strongly related 
to smoking and alcohol misuse and is less likely to occur among patients who are female, 
privately insured, have a higher quartile of income or are admitted for elective PCI. Whilst 
the rates of DAMA appear to be rising, it is still a relatively rare occurrence. We show that 
patients who DAMA are a high-risk cohort. They have a 2-fold increased risk of readmission 
and are twice as likely to be readmitted with the diagnosis-code of acute MI and four times as 
likely to be readmitted with an acute neuropsychiatric episode. To the best of our knowledge, 
we show, for the first time, that DAMA is one of the strongest predictors of unplanned 30-
day readmission after PCI. Our results provide evidence that patients who DAMA should be 
considered to be at high risk. Our findings support the need for a greater understanding of 
12 
 
patients who DAMA to further develop interventions to either reduce it or the development of 
pathways that allow follow up of patients that DAMA. 
Our study provides novel insight into patients who DAMA after PCI, and temporal 
trends, predictors and outcomes associated with DAMA in PCI have not been explored 
before. It is unclear whether the observed changes are a result of changes in the demographics 
of the patients that present for PCI or because of changes in the care delivered which may 
influence patient decisions.  We show evidence which is consistent with literature outside the 
PCI setting that being young and male are factors associated with DAMA. We also find that 
smokers and patients who misuse alcohol are at higher risk and decisions to DAMA in these 
patients may be motivated by substance seeking behaviour.  
Our findings suggest that patients undergoing elective procedures are less likely to 
DAMA which suggests that there may be an element of selection bias for such procedures, 
with patients in which there may be issues around compliance or future engagement with 
healthcare less likely to be offered an elective PCI. In contrast, in PCI procedures undertaken 
in the acute setting of an acute MI, selection based on future compliance / engagement with 
healthcare services is not feasible, which may explain the increased risk of DAMA associated 
with the re-admission diagnosis-code of MI. 
 We show, for the first time, the reasons for readmissions after DAMA in patients who 
undergo PCI.  A key finding here is that patients who DAMA have a four-fold increased rates 
of neuropsychiatric unplanned 30-day readmissions compared to patients discharged home. 
Our detailed analysis of specific causes of readmission suggests that depression, bipolar and 
mood disorders are most common reasons for readmission with previous literature reporting 
that coronary artery intervention can increase patients’ anxiety and depression.10 In the 
current study, both, smoking11 and alcohol misuse12 were independently associated with 
DAMA and these two factors have also been linked to mental illness. We also report that 
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patients who DAMA are twice as likely to be readmitted with the diagnosis-code of acute MI. 
This is an important finding, and may relate to failure to prescribe dual antiplatelet therapy 
(DAPT) to patients who DAMA, or failure for their continuing prescription once discharged 
which significantly increases the risk of stent thrombosis. It is unclear from this study, 
whether patients who DAMA were prescribed medications such as antiplatelet agents prior to 
DAMA or whether these patients had any follow up with medical services once discharged 
for continued receipt of pharmacotherapy. Interestingly, one study of general admissions 
suggests that only 21.4% of patients had medications prescribed when patients discharged 
against medical advice.13 
DAMA in the context of PCI are unlike DAMA in the emergency department and 
general hospital admissions which have been reported in the literature.14-16 A patient who is 
seen at the emergency department may not receive treatment and similarly a patient admitted 
to hospital may be admitted for investigations and observation initially. In contrast, patients 
who undergo PCI have received a treatment that requires ongoing management and medical 
therapy to ensure optimal future outcomes. In patients who DAMA at some point after the 
procedure, there is a breakdown in the care relationship and the patient chooses to 
discontinue care. This can have serious consequences as ongoing patient care is required after 
PCI, with prescription of dual antiplatelet therapy to reduce the risk of stent thrombosis or an 
echocardiogram to assess for left ventricular function after an acute event enabling 
prescription of evidence based therapies that reduce the risk of re-hospitalization,17 or 
management of newly diagnosed diabetes mellitus and so forth. Furthermore, whereas a 
patient who DAMA in the emergency department and general hospital inpatient stay may 
carry the risks associated with the presenting condition, the patients who undergo PCI may 
carry the risks associated to their presenting condition but also those related to their treatment 
(PCI).  
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The need for interventions for DAMA patients 
Our findings suggest that an evidence basis around understanding reasons for DAMA 
in the context of PCI should be developed, with interventions developed to reduce DAMA or 
at least obviate the risks in situations where it does occur. A previous qualitative study 
proposed several strategies to reduce DAMA in cardiovascular disease.9 First, patients 
highlighted that communications needed to be improved and healthcare providers should 
receive training in cultural diversity, interpersonal skills, customer service and also be more 
truthful and accurate regarding wait times. Nurses further suggested that the quality of verbal 
communication needed to be improved to manage patient’s expectations in order to minimise 
false promises. The principles of these findings could potentially be applied to settings where 
PCI has been undertaken to potentially reduce rates of DAMA. Secondly, in cases where 
DAMA has occurred, interventions need to be developed to obviate potential risks, 
particularly around the prescription of DAPT and other cardiac medications in this patient 
group. This may require the development of targeted interventions across healthcare 
providers spanning the secondary and primary care interface, or the development of 
pharmacy outreach programs that enable prescription / continuation of therapies in the 
community. Finally, given that neuropsychiatric causes are an important cause of unplanned 
30-day readmissions in patients who DAMA, involvement of psychiatric services, 
particularly in those with a history of mental health conditions or a history of substance abuse 
early on in the index admission for patients undergoing PCI particularly in the acute setting, 
may decrease the risk of DAMA or at least provide an arena for safer “discharge” planning, 
even in those who do subsequently DAMA.   Another area of future work should explore the 
care that patients are deprived of by choosing to DAMA.  There is likely a portion of patients 
who require further treatment and these patients may be at higher risk of adverse events but 
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also patients who have received PCI treatment and are recommended to stay in hospital for a 
period of observation. 
Strengths and limitations of the study 
Our study has several strengths. This is the first study to evaluate DAMA in the context 
of PCI in a large cohort that has sufficient sample size to capture these uncommon events.  
Secondly, the data from the NRD is largely complete which minimises biases related to 
missing data. Finally, we were able to adjust for a variate of confounders in our models to 
predict DAMA and 30-day readmission including many socioeconomic factors, 
comorbidities, hospital characteristics, procedural variables and outcomes.    
There are several limitations in the current study. First, the overall data is derived 
from five unique datasets corresponding to each in the period between 2010 to 2014 and no 
linkage is possible between years. Secondly, the dataset does not capture pharmacotherapy 
data such as DAPT and thus prescription fill-rates and compliance are unknown in patients 
who DAMA. Thirdly, whilst we report a two-fold increased odds of re-admission with 
diagnosis-code of acute MI in patients who DAMA, there are no diagnostic codes for stent 
thrombosis and so we were unable to determine whether this increased risk relates to stent 
thrombosis events, or reflects in worse cardiovascular risk factor profile in patients who self-
discharge for de-novo events. Fourthly, the study is a retrospective analysis of an 
administrative database which was collected from administrative claims sampled from 21 
states but may not be generalizable to all settings, since regional heterogeneity was not 
explored. In addition, we were unable to capture out of hospital deaths so our results may 
underestimate the extent of poor outcomes associated with patients who DAMA. Also, we 
were not able to exclude the possibility that the same patient may appear in multiple years 
because the data is composed of five annual datasets, which cannot be linked across years. 
Furthermore, as with any such administrative database, coding errors are always a potential 
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source of bias, as is underreporting of secondary and co-morbid diagnosis. Finally, causes of 
readmission were identified using the primary discharge diagnosis codes which may be 
subject to reporting biases. 
In conclusion, DAMA occurs in 0.5% of patients who undergo PCI and is strongly 
associated with a greater risk of 30-day unplanned readmission with higher mortality.   We 
identified that patients who have previous myocardial infarction, are smokers and misuse 
alcohol and drugs are most likely to DAMA.  This information may be useful for clinicians to 
identify those patients upon admission or shortly after that are at high-risk of DAMA 
allowing clinicians to better tailor care so that the management is supported and agreed by 
these patients and there is no breakdown in the therapeutic relationship. 
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List of Tables and Figures 
Figure 1: Flow diagram of participants 
 
Figure 1 caption: Figure showing the flow diagram of patients included in the analysis and 
the proportion of patients who discharge against medical advice (DAMA) and patients who 
are discharged home and their respective 30-day readmission rates. 
Figure 2: Percentage of patients who undergo percutaneous coronary intervention and 
discharge against medical advice (DAMA) 
 
Figure 2 caption: Figure showing the increase in patients who discharge against medical 
advice (DAMA) over time.
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Table 1: Patient characteristics at index hospital admission according stratified by whether 
patients discharged against medical advice (DAMA) 
Variable Not DAMA 
n=2,011,055 
DAMA 
n=10,049 
p-value 
Age (years) 63.7±12.0 57.2±11.9 <0.001 
Women, % 30.6% 18.9% <0.001 
Elective 17.3% 8.2% <0.001 
Weekend 20.0% 23.4% <0.001 
Diagnosis of acute myocardial infarction 50.7% 65.7% <0.001 
Primary expected payer  <0.001 
Medicare 49.3% 40.9%  
Medicaid 7.7% 19.8%  
Private 32.3% 16.1%  
Uninsured 6.1% 16.5%  
No charge 0.8% 1.7%  
Other 3.8% 5.1%  
Median household income (percentile)  <0.001 
0-25th 28.8% 35.6%  
26-50th 25.3% 26.8%  
51-75th 24.0% 22.7%  
76-100th 22.0% 15.0%  
Smoker 42.7% 65.6% <0.001 
Alcohol misuse 2.6% 8.4% <0.001 
Dyslipidemia 72.8% 59.9% <0.001 
Hypertension 74.4% 70.7% <0.001 
Diabetes mellitus 35.7% 35.0% 0.34 
Obesity 15.9% 15.4% 0.35 
Heart failure 0.7% 1.6% <0.001 
Known coronary artery disease 94.6% 91.8% <0.001 
Previous myocardial infarction 14.3% 19.6% <0.001 
Previous percutaneous coronary 
intervention 
21.3% 25.4% <0.001 
Previous coronary artery bypass graft 7.8% 7.5% 0.43 
Previous valve disease 0.2% 0.4% 0.17 
Atrial fibrillation 9.8% 7.9% <0.001 
Previous transient ischemic 
attack/stroke 
6.1% 6.9% 0.018 
Peripheral vascular disease 10.2% 10.7% 0.29 
Pulmonary circulatory disorder 0.1% 0.3% 0.04 
Peptic ulcer disease 0.02% 0.00% 0.33 
Chronic lung disease 15.4% 22.0% <0.001 
Renal failure 11.4% 12.3% 0.064 
Liver disease 1.2% 2.0% <0.001 
Hypothyroidism 8.5% 4.3% <0.001 
Fluid and electrolyte disorders 9.9% 13.8% <0.001 
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Anemia 8.5% 9.7% 0.007 
Cancer 1.6% 1.5% 0.5 
Depression 6.1% 7.0% 0.025 
Dementia 1.1% 0.9% 0.41 
Charlson comorbidity index 1.2±1.3 1.3±1.4 <0.001 
Mean number of comorbidities 4.7±2.0 5.0±2.1 <0.001 
Bed size   0.02 
Small 5.8% 4.8%  
Medium 20.7% 21.0%  
Large 73.5% 74.2%  
Location   0.43 
Rural 0.2% 0.3%  
Urban 99.8% 99.8%  
Teaching status   <0.001 
Nonteaching 45.4% 49.8%  
Teaching status 54.7% 50.2%  
In-hospital procedures and procedural details  
Multivessel disease 16.1% 12.6% <0.001 
Bifurcation 2.9% 2.2% 0.013 
Circulatory support 2.1% 3.4% <0.001 
Vasopressor use 0.3% 0.3% 0.74 
Intra-aortic balloon pump 1.8% 3.2% <0.001 
Fractional flow reserve 1.9% 1.1% <0.001 
Intravascular ultrasound 7.1% 5.3% <0.001 
Drug eluting stent 75.8% 59.2% <0.001 
In-hospital outcomes   
Complete heart block 0.8% 0.9% 0.37 
Transient ischemic attack/stroke 2.5% 2.5% 0.97 
Cardiogenic shock 1.7% 3.4% <0.001 
Cardiac arrest 1.2% 2.1% <0.001 
Acute kidney injury 0.4% 1.1% <0.001 
Major bleeding 0.4% 1.1% <0.001 
Blood transfusion 0.4% 1.1% 0.33 
Vascular complication 0.6% 0.5% 0.26 
Emergency coronary artery bypass graft 0.7% 0.5% 0.16 
Length of stay, days 3.0±3.2 3.2±7.7 <0.001 
Cost for first admission $19732±12,168 $20441±17759 <0.001 
Readmission    
30-day readmission 8.5% 16.8% <0.001 
Cost of readmission $11380±15857 $13717±18774 <0.001 
Percentages presented for categorical variables and means and standard deviations for continuous 
variables. 
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Table 2: Patient characteristics according to whether they discharged against medical advice and readmission status  
Variable Not readmitted   Readmitted   
 Not DAMA 
n=1,840,178 
DAMA 
n=8,364 
p-value Not DAMA 
n=170,877 
DAMA 
n=1,685 
p-value 
Age (years) 63.5±12.0 57.1±11.7 <0.001 65.2±12.6 58.0±12.6 <0.001 
Women, % 30.0% 18.6% <0.001 37.3% 20.7% <0.001 
Elective 17.8% 8.7% <0.001 12.2% 6.0% <0.001 
Weekend 19.9% 23.5% <0.001 21.0% 23.1% 0.18 
Diagnosis of acute myocardial infarction 50.9% 66.1% <0.001 48.9% 63.6% <0.001 
Primary expected payer  <0.001   <0.001 
Medicare 48.4% 39.6%  58.2% 46.8%  
Medicaid 7.5% 19.2%  10.0% 22.7%  
Private 33.2% 16.7%  22.6% 13.0%  
Uninsured 6.2% 17.6%  4.9% 11.1%  
No charge 0.9% 1.8%  0.8% 1.4%  
Other 3.9% 5.1%  3.5% 5.0%  
Median household income (percentile)  <0.001   <0.001 
0-25th 28.6% 35.1%  30.9% 38.1%  
26-50th 25.2% 27.3%  25.4% 24.2%  
51-75th 24.0% 23.0%  23.4% 21.2%  
76-100th 22.1% 14.6%  20.2% 16.6%  
Smoker 42.8% 66.0% <0.001 41.4% 63.7% <0.001 
Alcohol misuse 2.6% 7.9% <0.001 2.8% 10.7% <0.001 
Dyslipidemia 73.0% 59.8% <0.001 70.4% 60.1% <0.001 
Hypertension 74.1% 69.7% <0.001 77.9% 75.9% 0.22 
Diabetes mellitus 35.0% 33.6% 0.085 43.0% 41.7% 0.51 
Obesity 15.9% 15.3% 0.36 16.2% 15.7% 0.75 
Heart failure 0.7% 1.5% <0.001 1.3% 2.1% 0.082 
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Known coronary artery disease 94.6% 92.1% <0.001 94.9% 90.5% <0.001 
Previous myocardial infarction 14.2% 19.5% <0.001 15.8% 20.2% 0.001 
Previous percutaneous coronary 
intervention 
21.2% 25.6% <0.001 22.3% 24.2% 0.22 
Previous coronary artery bypass graft 7.7% 7.2% 0.33 9.4% 8.8% 0.59 
Previous valve disease 0.2% 0.3% 0.5 0.4% 0.7% 0.3 
Atrial fibrillation 9.3% 7.0% <0.001 14.8% 12.4% 0.72 
Previous transient ischemic attack/stroke 5.8% 6.1% 0.46 8.7% 11.0% 0.028 
Peripheral vascular disease 9.8% 10.1% 0.53 14.1% 13.4% 0.58 
Pulmonary circulatory disorder 0.1% 0.2% 0.11 0.3% 0.4% 0.41 
Peptic ulcer disease 0.02% 0.00% 0.37 0.02% 0.00% 0.67 
Chronic lung disease 14.8% 20.9% <0.001 22.2% 28.0% <0.001 
Renal failure 10.6% 10.7% 0.92 19.6% 20.3% 0.66 
Liver disease 1.1% 1.8% <0.001 1.8% 3.1% 0.014 
Hypothyroidism 8.3% 4.1% <0.001 10.5% 5.4% <0.001 
Fluid and electrolyte disorders 9.4% 12.2% <0.001 14.8% 21.8% <0.001 
Anemia 7.9% 8.3% 0.37 15.2% 16.4% 0.39 
Cancer 1.5% 1.4% 0.56 2.5% 1.8% 0.27 
Depression 5.9% 6.6% 0.09 8.4% 8.8% 0.75 
Dementia 1.0% 0.8% 0.15 1.8% 1.8% 0.94 
Charlson comorbidity index 1.1±1.3 1.3±1.4 <0.001 1.6±1.6 1.8±1.6 0.004 
Mean number of comorbidities 4.7±2.0 4.9±2.1 <0.001 5.3±2.2 5.6±2.2 <0.001 
Bed size   0.037   0.29 
Small  5.9% 4.9%  5.1% 4.3%  
Medium 20.7% 21.4%  20.5% 18.8%  
Large 73.4% 73.6%  74.4% 76.9%  
Location   0.52   0.54 
Rural 0.2% 0.3%  0.2% 0.3%  
Urban 99.8% 99.7%  99.8% 99.7%  
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Teaching status   <0.001   0.032 
Nonteaching 45.3% 49.7%  46.1% 50.1%  
Teaching status 54.7% 50.3%  53.9% 49.9%  
In-hospital procedures and procedural details     
Multivessel disease 16.1% 12.6% <0.001 16.2% 12.5% 0.008 
Bifurcation 2.9% 2.3% 0.028 2.7% 2.1% 0.31 
Circulatory support 2.0% 2.9% <0.001 3.0% 5.6% <0.001 
Vasopressor use 0.3% 0.2% 0.25 0.4% 0.7% 0.19 
Intra-aortic balloon pump 1.7% 2.8% <0.001 2.7% 5.0% <0.001 
Fractional flow reserve 1.9% 1.1% <0.001 2.1% 1.5% 0.31 
Intravascular ultrasound 7.1% 5.3% <0.001 7.2% 4.9% 0.017 
Drug eluting stent 76.3% 60.2% <0.001 70.9% 54.4% <0.001 
In-hospital outcomes      
Complete heart block 0.8% 1.0% 0.16 0.9% 0.6% 0.32 
Transient ischemic attack/stroke 2.4% 2.2% 0.39 3.0% 3.8% 0.27 
Cardiogenic shock 1.6% 2.8% <0.001 2.5% 6.4% <0.001 
Cardiac arrest 1.2% 2.0% <0.001 1.4% 2.6% 0.004 
Acute kidney injury 0.3% 1.0% <0.001 0.7% 1.8% <0.001 
Major bleeding 0.4% 1.0% <0.001 0.7% 1.8% <0.001 
Blood transfusion 0.02% 0.00% 0.39 0.03% 0.00% 0.63 
Vascular complication 0.6% 0.4% 0.13 0.8% 0.8% 0.87 
Emergency coronary artery bypass graft 0.7% 0.5% 0.091 0.7% 0.8% 0.86 
Length of stay, days 2.9±3.2 3.1±8.3 0.009 3.6±3.0 3.7±3.9 0.51 
Cost for first admission $19606±12182 $20030±18138 0.04 $21090±11938 $22469±15606 0.002 
Readmission       
30-day readmission - - - 100.0% 100.0% - 
Cost of readmission - - - $11380±15857 $13718±18774 0.001 
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Table 3: Readmission outcomes in all patients readmitted and those with elective index PCI 
and acute myocardial infarction for index PCI 
All readmissions Not DAMA at 
index PCI 
DAMA at index 
PCI 
p-value 
Death in readmission 2.0% 3.2% 0.017 
In-hospital MACE for readmission 2.4% 6.1% <0.001 
Cost of readmission $11,380±15,857 $13,718±18,774 <0.001 
Discharge against medical advice for 
readmission 
1.1% 13.9% <0.001 
Acute myocardial infarction    
Death in readmission 2.4% 5.0% <0.001 
In-hospital MACE for readmission 2.5% 7.3% <0.001 
Cost of readmission $11,936±15,941 $15,183±20,851 <0.001 
Discharge against medical advice for 
readmission 
1.1% 12.2% <0.001 
MACE defined as primary diagnosis of acute myocardial infarction, stroke or TIA, re-PCI, 
emergency CABG and in-hospital death. 
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Table 4: Multiple logistic regression to identify independent variables associated with 
patients who discharge against medical advice 
Variables Odds ratio (95%CI) p-value 
Age (per 1 year increment) 0.96 (0.95-0.96) <0.001 
Female 0.58 (0.53-0.64) <0.001 
Elective 0.66 (0.57-0.76) <0.001 
Diagnosis of acute myocardial infarction 1.37 (1.25-1.51) <0.001 
Primary expected payer vs Medicare  
Medicaid 1.23 (1.09-1.39) 0.001 
Private 
Other 
0.32 (0.28-0.36) 
0.73 (0.61-0.87) 
<0.001 
0.001 
Median household income (percentile) vs 0-25th 
76-100th 0.88 (0.79-0.87) 0.041 
Smoker 1.71 (1.57-1.86) <0.001 
Alcohol misuse 1.53 (1.32-1.78) <0.001 
Drug abuse 1.82 (1.60-2.06) <0.001 
Dyslipidemia 0.63 (0.58-0.68) <0.001 
Diabetes mellitus 1.12 (1.03-1.21) 0.008 
Obesity 0.89 (0.80-0.98) 0.019 
Heart failure 1.66 (1.17-2.37) 0.005 
Known coronary artery disease 0.83 (0.73-0.95) 0.006 
Previous myocardial infarction 1.33 (1.20-1.48) <0.001 
Previous percutaneous coronary 
intervention 
1.34 (1.22-1.48) <0.001 
Previous coronary artery bypass graft 1.16 (1.01-1.37) 0.041 
Peripheral vascular disease 1.19 (1.05-1.35) 0.006 
Chronic lung disease 1.31 (1.20-1.43) <0.001 
Renal failure 1.18 (1.05-1.33) 0.005 
Hypothyroidism 0.73 (0.61-0.87) <0.001 
Fluid and electrolyte disorders 1.12 (1.03-1.25) 0.041 
Dementia 1.52 (1.03-2.24) 0.036 
Teaching status 0.81 (0.74-0.89) <0.001 
Intravascular ultrasound 0.79 (0.66-0.94) 0.008 
Drug eluting stent 0.64 (0.59-0.70) <0.001 
Acute kidney injury 2.45 (1.73-3.48) <0.001 
Emergency coronary artery bypass graft 0.42 (0.27-0.68) <0.001 
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Table 5: Multiple logistic regression to determine independent variables associated with 
readmission within 30 days 
A) All patients 
Variables Odds ratio (95%CI) p-value 
Discharge against medical advice 1.89 (1.71-2.08) <0.001 
Age (per 1 year increment) 1.00 (1.00-1.00) 0.011 
Female 1.23 (1.21-1.26) 0.001 
Elective 0.62 (0.59-0.64) <0.001 
Diagnosis of acute myocardial infarction 0.89 (0.87-0.91) <0.001 
Primary expected payer vs Medicare  
Medicaid 1.12 (1.08-1.17) <0.001 
Private 0.70 (0.68-0.72) <0.001 
Uninsured 0.74 (0.71-0.78) <0.001 
No charge 0.89 (0.80-0.99) 0.031 
Other 0.82 (0.78-0.87) <0.001 
Median household income (percentile) vs 0-25th 
26-50th 0.97 (0.93-0.97) <0.001 
76-100th 0.96 (0.92-0.99) 0.012 
Smoker 0.95 (0.93-0.97) <0.001 
Drug abuse 1.35 (1.28-1.43) <0.001 
Dyslipidemia 0.88 (0.86-0.90) <0.001 
Hypertension 1.07 (1.04-1.09) <0.001 
Diabetes mellitus 1.21 (1.18-1.23) <0.001 
Obesity 0.94 (0.91-0.96) <0.001 
Previous coronary artery bypass graft 1.09 (1.05-1.13) <0.001 
Atrial fibrillation 1.41 (1.37-1.45) <0.001 
Previous transient ischemic attack/stroke 1.19 (1.14-1.22) <0.001 
Peripheral vascular disease 1.18 (1.14-1.23) <0.001 
Chronic lung disease 1.38 (1.34-1.42) <0.001 
Renal failure 1.48 (1.44-1.53) <0.001 
Liver disease 1.37 (1.27-1.47) <0.001 
Hypothyroidism 1.04 (1.00-1.07) 0.035 
Fluid and electrolyte disorders 1.21 (1.18-1.25) <0.001 
Anemia 1.36 (1.32-1.40) <0.001 
Cancer 1.39 (1.30-1.49) <0.001 
Depression 1.24 (1.20-1.29) <0.001 
Dementia 1.25 (1.16-1.35) <0.001 
Teaching hospital 0.97 (0.94-0.99) 0.017 
Intra-aortic balloon pump 1.21 (1.01-1.46) 0.041 
Fractional flow reserve 1.09 (1.02-1.17) 0.011 
Drug eluting stent 0.84 (0.83-0.86) <0.001 
Cardiogenic shock 1.12 (1.04-1.20) 0.002 
Vascular complication 1.13 (1.01-1.25) 0.032 
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Emergency coronary artery bypass graft 0.86 (0.76-0.96) 0.010 
 
B) Elective only 
Variables Odds ratio (95%CI) p-value 
Discharge against medical advice 1.91 (1.17-3.11) 0.010 
Female 1.27 (1.19-1.35) <0.001 
Primary expected payer vs Medicare  
Private 0.73 (0.66-0.80) <0.001 
Dyslipidemia 0.89 (0.82-0.96) 0.003 
Diabetes mellitus 1.13 (1.05-1.22) 0.001 
Previous percutaneous coronary 
intervention 
0.86 (0.80-0.93) <0.001 
Atrial fibrillation 1.38 (1.24-1.53) <0.001 
Previous transient ischemic attack/stroke 1.25 (1.09-1.43) 0.002 
Peripheral vascular disease 1.18 (1.07-1.30) 0.001 
Chronic lung disease 1.35 (1.23-1.48) <0.001 
Renal failure 1.46 (1.34-1.60) <0.001 
Liver disease 1.49 (1.11-2.00) 0.008 
Fluid and electrolyte disorders 1.31 (1.14-1.52) <0.001 
Anemia 1.42 (1.24-1.62) <0.001 
Cancer 1.33 (1.03-1.72) 0.031 
Depression 1.38 (1.20-1.60) <0.001 
Fractional flow reserve 1.31 (1.08-1.60) 0.007 
Drug eluting stent 0.83 (0.77-0.91) <0.001 
Vascular complication 1.42 (1.06-1.88) 0.020 
Emergency coronary artery bypass graft 1.41 (1.06-1.88) 0.018 
 
C) Acute myocardial infarction 
Variables Odds ratio (95%CI) p-value 
Discharge against medical advice 1.96 (1.73-2.22) <0.001 
Female 1.29 (1.25-1.33) <0.001 
Primary expected payer vs Medicare  
Medicaid 1.19 (1.12-1.26) <0.001 
Private 0.70 (0.67-0.73) <0.001 
Uninsured 0.75 (0.71-0.80) <0.001 
Other 0.82 (0.76-0.88) <0.001 
Smoker 0.91 (0.89-0.94) <0.001 
Drug abuse 1.30 (1.20-1.40) <0.001 
Dyslipidemia 0.90 (0.87-0.93) <0.001 
Hypertension 1.09 (1.05-1.13) <0.001 
Diabetes mellitus 1.21 (1.18-1.23) <0.001 
Obesity 0.90 (0.87-0.94) <0.001 
28 
 
Previous heart failure 0.76 (0.59-0.98) 0.033 
Atrial fibrillation 1.40 (1.39-1.52) <0.001 
Previous transient ischemic attack/stroke 1.19 (1.13-1.26) <0.001 
Peripheral vascular disease 1.21 (1.15-1.27) <0.001 
Chronic lung disease 1.38 (1.32-1.43) <0.001 
Renal failure 1.52 (1.46-1.59) <0.001 
Liver disease 1.30 (1.16-1.45) <0.001 
Fluid and electrolyte disorders 1.21 (1.16-1.26) <0.001 
Anemia 1.36 (1.30-1.43) <0.001 
Cancer 1.54 (1.40-1.70) <0.001 
Depression 1.18 (1.11-1.25) <0.001 
Dementia 1.32 (1.18-1.47) <0.001 
Teaching hospital 0.96 (0.93-0.99) 0.023 
Intra-aortic balloon pump 1.38 (1.03-1.84) 0.031 
Fractional flow reserve 1.14 (1.00-1.30) 0.046 
Drug eluting stent 0.82 (0.79-0.84) <0.001 
Cardiogenic shock 1.10 (1.01-1.20) 0.029 
Emergency coronary artery bypass graft 0.85 (0.73-1.00) 0.047 
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Table 6: Cause of readmission by discharge against medical advice status 
A) Causes of readmissions 
Cause of readmission Not DAMA (%) DAMA (%) 
Cardiac 45.5 49.8 
Non-cardiac 54.5 50.2 
 
B) Causes of non-cardiac readmissions 
Cause of non-cardiac readmission Not DAMA (%) DAMA (%) 
Non-specific chest pain 20.2 19.7 
Infections 9.3 10.2 
Respiratory 7.5 9.7 
Neuropsychiatric 2.4 8.3 
Gastrointestinal 11.4 6.9 
Peripheral vascular disease 4.4 5.0 
Renal failure 3.2 3.9 
Bleeding 5.3 3.6 
TIA/stroke 4.4 3.0 
Hematological/neoplasm 2.7 2.2 
 
C) Causes of cardiac readmissions 
Cause of cardiac readmission Not DAMA (%) DAMA (%) 
Diagnosis of acute myocardial infarction 19.5 39.4 
Coronary artery disease including angina 42.4 29.3 
Heart failure 19.1 17.6 
Arrhythmias 14.0 11.5 
Pericarditis 1.4 0.8 
Valve disorders 0.7 0.6 
Conduction disorders 0.7 0.0 
Hyper/hypotension 0.0 0.0 
Other cardiac 2.1 0.8 
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Supplementary Methods 
Study design and participants 
 The Nationwide Readmission Database (NRD) is a publicly available database of all-
payer hospital inpatients stays, which is developed by the Agency for Healthcare Research 
and Quality (AHRQ) as a part of the Healthcare Cost and Utilization Project (HCUP) in the 
Unites States.  Its data are derived from State Inpatient Databases that contain unique patient 
number which can be used to track patients across different hospitals within a State whilst 
adhering to privacy guidelines. The data are drawn from 21 states that are geographically 
dispersed and accounts for approximately 49% of total US resident population and 
approximately 49% of hospitalizations.  Following the recommendations of AHRQ we used 
the discharge weights provided in the dataset to estimate total sample sizes. 
In the current study, we included men and women aged 18 years or older who 
underwent first PCI between 2010 and 2014 and were either DAMA or were discharged 
home.  First PCI was defined by first procedure of PCI within a calendar year.  DAMA was 
defined from the variable "DISPUNIFORM" which represents the disposition of patient at 
discharge. Patients who had a discharge destination of either DAMA or discontinued care 
were considered to be DAMA.  We excluded patients who died during their index admission 
for PCI, those who had an elective readmission and those who were not discharged home or 
against medical advice (transfer to another institution, care home or unknown destination).    
 
Variables and outcomes 
 We collected data on participant age, sex, year of procedure, elective procedure, 
weekend admission, primary expected payer and quartile of median household income and 
used International Classification of Disease – 9th Clinical Modification (ICD-9) and Clinical 
classification software (CCS) of diseases codes to determine comorbidities, in-hospital 
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procedures and outcomes. The comorbidities collected included smoking, alcohol misuse, 
dyslipidemia, hypertension, diabetes mellitus, obesity, heart failure, known coronary artery 
disease, previous myocardial infarction (MI), previous PCI, previous coronary artery bypass 
graft (CABG), previous valve disease, atrial fibrillation, previous TIA (transient ischemic 
attack) / stroke, peripheral vascular disease, pulmonary circulatory disorder, peptic ulcer 
disease, chronic lung disease, chronic kidney disease, liver disease, hypothyroidism, fluid and 
electrolyte disorders, anemia, cancer, depression and dementia. The hospital characteristics 
evaluated included the number of beds per hospital, location and teaching status. The in-
hospital procedures and related variables collected were multivessel disease, bifurcation 
disease, circulatory support, vasopressor use, intra-aortic balloon pump, fractional flow 
reserve, intravascular ultrasound and drug eluting stent. The outcomes evaluated were in-
hospital complete heart block, TIA/stroke, cardiogenic shock, cardiac arrest, acute kidney 
injury, major bleeding, blood transfusion, vascular complication, emergency CABG, length 
of stay (LOS) in days and cost for clinical care. The cost of clinical care was determined by 
the claims change multiplied by the cost-to-charge ratio. 30-day readmissions were defined as 
first rehospitalization after discharge within 30 days from admission for PCI.  The causes of 
readmissions were determined from the principle diagnosis based on CCS codes as outlined 
in Supplementary Table 1. The primary endpoint was all-cause 30-day readmissions and 
reasons for readmissions.   
Statistical analysis 
Statistical analysis was performed using Stata 14.0 (College Station, Texas, USA).  A 
flow diagram was used to determine the proportion of patients at each stage of the analysis 
and those who were readmitted as well as those who died on readmission. Descriptive 
statistics were used to compare patients who were DAMA compared to those who were 
discharged home with further stratification depending on whether or not they were 
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readmitted.  Statistical differences between groups for continuous variables were tested using 
the t-test and for categorical variables the Chi2 test.  For all analyses, the survey estimation 
commands were used (e.g. svy: logistic for multiple logistic regression), following the 
recommendations from AHRQ for analysis of survey data to account for the complex survey 
design of the NRD database. Multiple logistic regression with adjustments for age, gender, 
year of PCI, elective procedure, weekend admission, primary expected payer, quartile of 
median household income, comorbidities, hospital characteristics, in-hospital procedures and 
in-hospital outcomes were used to determine independent variables associated with DAMA 
and 30-day readmission. The major cardiac and non-cardiac causes of readmission for the 
DAMA and discharged home groups are presented in tables. 
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Supplementary Table 1: Classification of Clinic Classification Software codes for Readmissions 
Causes 
Causes of readmission CCS 
code 
Diagnosis 
Respiratory 127 Chronic obstructive pulmonary disease and bronchiectasis 
128 Asthma 
130 Pleurisy, pneumothorax, pulmonary collapse 
131 Respiratory failure, insufficiency and arrest 
132 Lung disease due to external agents 
133 Other lower respiratory disease 
134 Other upper respiratory disease 
221 Respiratory distress syndrome 
Infection 1 Tuberculosis 
2 Septicemia 
3 Bacterial infection 
4 Mycoses 
5 HIV infection 
6 Hepatitis 
7 Viral infection 
8 Other infection 
9 Sexually transmitted infection 
76 Meningitis 
77 Encephalitis 
78 Other CNS infection and poliomyelitis 
90 Inflammation or infection of eye 
122 Pneumonia 
123 Influenza 
124 Acute and chronic tonsillitis 
125 Acute bronchitis 
126 Other upper respiratory infections 
129 Aspiration pneumonitis 
135 Intestinal infection 
197 Skin and subcutaneous tissue infections 
201 Infective arthritis and osteomyelitis (except that caused by tuberculosis or 
sexually transmitted disease) 
Bleeding  60 Acute posthemorrhagic anemia 
153 Gastrointestinal hemorrhage 
182 Hemorrhage during pregnancy; abrutio placenta; placenta previa 
Peripheral vascular disease  114 Peripheral and visceral atherosclerosis 
115 Aortic, peripheral and visceral artery aneurysms 
116 Aortic and peripheral arterial embolism or thrombosis 
117 Other circulatory disease 
118 Phlebitis, thrombophlebitis and thromboembolism 
119 Varicose veins of lower extremities 
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Genitourinary  159 Urinary tract infection 
160 Calculus of the urinary tract 
161 Other diseases of kidney and ureters 
162 Other diseases of bladder and urethra 
163 Genitourinary symptoms and ill-defined conditions 
164 Hyperplasia of prostate 
165 Inflammatory conditions of the male genital organs 
166 Other male genital disorders 
170 Prolapse of female genital organs 
175 Other female genital disorders 
215 Genitourinary congenital anomalies 
Renal disease 156 Nephritis; nephrosis; renal sclerosis 
157 Acute and unspecified renal failure 
158 Chronic kidney disease 
Gastrointestinal  138 Esophageal disorders 
139 Gastroduodenal ulcer (except hemorrhage) 
140 Gastritis and duodenitis 
141 Other disorders of stomach and duodenum 
142 Appendicitis and other appendiceal conditions 
143 Abdominal hernia 
144 Regional enteritis and ulcerative colitis 
145 Intestinal obstruction without hernia 
146 Diverticulosis and diverticulitis 
147 Anal and rectal conditions 
148 Peritonitis and intestinal abscess 
149 Biliary tract disease 
150 Liver disease; alcohol-related 
151 Other liver diseases 
152 Pancreatic disorders (not diabetes) 
154 Noninfectious gastroenteritis 
155 Other gastrointestinal disorders 
214 Digestive congenital anomalies 
222 Hemolytic jaundice and perinatal jaundice 
250 Nausea and vomiting 
251 Abdominal pain 
TIA/stroke 109 Acute cerebrovascular disease 
110 Occlusion of stenosis of precerebral arteries 
111 Other and ill-defined cerebrovascular disease 
112 Transient cerebral ischemia 
113 Late effects of cerebrovascular disease 
Trauma 207 Pathological fracture 
225 Joint disorders and dislocations; trauma-related 
226 Fracture of neck of femur (hip) 
227 Spinal cord injury 
228 Skull and face fractures 
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229 Fracture of upper limb 
230 Fracture of lower limb 
231 Other fractures 
232 Sprains and strains 
233 Intracranial injury 
234 Crushing injury or internal injury 
235 Open wounds of head; neck; and trunk 
236 Open wounds of extremities 
239 Superficial injury; contusion 
244 Other injuries and conditions due to external causes 
260 All (external causes of injury and poisoning) 
Endocrine/metabolic 48 Thyroid disorders 
49 Diabetes mellitus without complication 
50 Diabetes mellitus with complication 
51 Other endocrine disorders 
53 Disorders of lipid metabolism 
58 Other nutritional and endocrine/metabolic disorders 
186 Diabetes or abnormal glucose tolerance complicating pregnancy; childbirth; 
or the puerperium 
Neuropsychiatric  650 Adjustment disorders 
651 Anxiety disorders 
652 Attention-deficit, conduct, and disruptive behavior disorders 
653 Delirium, dementia, and amnestic and other cognitive disorders 
654 Developmental disorders 
655 Disorders usually diagnosed in infancy and childhood or adolescence 
656 Impulse control disorders, NEC 
657 Mood disorders 
658 Personality disorders 
659 Schizophrenia and other psychotic disorders 
660 Alcohol-related disorders 
661 Substance-related disorders 
662 Suicide and intentional self-inflicted injury 
663 Screening and history of mental health and substance abuse codes 
670 Miscellaneous mental health disorders 
79 Parkinson's disease 
80 Multiple sclerosis 
81 Other hereditary and degenerative nervous system conditions 
82 Paralysis 
83 Epilepsy, convulsions 
84 Headache including migraine 
85 Coma, stupor and brain damage 
95 Other nervous system disorders 
216 Nervous system congenital anomalies 
650 Adjustment disorders 
651 Anxiety disorders 
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652 Attention-deficit, conduct, and disruptive behavior disorders 
653 Delirium, dementia, and amnestic and other cognitive disorders 
654 Developmental disorders 
655 Disorders usually diagnosed in infancy and childhood or adolescence 
656 Impulse control disorders 
657 Mood disorders 
658 Personality disorders 
659 Schizophrenia and other psychotic disorders 
660 Alcohol-related disorders 
661 Substance-related disorders 
662 Suicide and intentional self-inflicted injury 
663 Screening and history of mental health and substance abuse codes 
670 Miscellaneous mental health disorders 
Hematological/neoplastic  11 Cancer of head and neck 
12 Cancer of esophagus 
13 Cancer of stomach 
14 Cancer of colon 
15 Cancer of rectum and anus 
16 Cancer of liver and intrahepatic bile ducts 
17 Cancer of pancreas 
18 Cancer of other gastrointestinal organs, peritoneum 
19 Cancer of bronchus, lung 
20 Cancer of other respiratory and intrathoracic 
21 Cancer of bone and connective tissue 
22 Melanoma of skin 
23 Other non-epithelial cancer of skin 
24 Cancer of breast 
25 Cancer of uterus 
26 Cancer of cervix 
27 Cancer of ovary 
28 Cancer of other female genital organs 
29 Cancer of prostate 
30 Cancer of testis 
31 Cancer of other male genital organs 
32 Cancer of bladder 
33 Cancer of kidney and renal pelvis 
34 Cancer of other urinary organs 
35 Cancer of brain and nervous system 
36 Cancer of thyroid 
37 Hodgkin's disease 
38 Non-Hodgkin's lymphoma 
39 Leukemias 
40 Multiple myeloma 
41 Cancer, other and unspecified primary 
42 Secondary malignancies 
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43 Malignant neoplasm without specification of site 
44 Neoplasm of unspecified nature or uncertain behavior 
46 Benign neoplasm of uterus 
47 Other and unspecified benign neoplasm 
59 Deficiency and other anemias 
61  Sickle cell anemia 
62 Coagulation and hemorrhagic disorders 
63 Disease of white blood cells 
64 Other hematologic conditions 
Rheumatology problem 54 Gout and other crystal arthropathies 
Opthalmology problem 86 Cataract 
87 Retinal detachment defects, vascular occlusion and retinopathy 
88 Glaucoma 
89 Blindness and vision defects 
91 Other eye disorders 
ENT problem 92 Otitis media and related conditions 
93 Conditions associate with dizziness or vertigo 
94 Other ear and sense organ disorder 
Non-specific chest pain 102 Non-specific chest pain 
Oral health problem 136 Disorders of teeth and jaw 
137 Diseases of mouth; excluding dental 
Obstetric admission 
including pregnancy 
174 Female infertility 
176 Contraceptive and procreative management 
177 Spontaneous abortion 
178 Induced abortion 
179 Postabortion complication 
180 Ectopic pregnancy 
181 Other complications of pregnancy 
184 Early or threatened labor 
185 Prolonged pregnancy 
187 Malposition; malpresentation 
188 Fetopelvic disproportion; obstruction 
189 Previous C-section 
190 Fetal distress and abnormal forces of labor 
191 Polyhydramnios and other problems of amniotic cavity 
192 Umbilical cord complication 
193 OB-related trauma to perineum and vulva 
194 Forceps delivery 
195 Other complications of birth; puerperium affecting management of mother 
196 Other pregnancy and deliver including normal 
218 Liveborn 
219 Short gestation; low birth weight; and fetal growth retardation 
220 Intrauterine hypoxia and birth asphyxia 
223 Birth trauma 
224 Other perinatal conditions 
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Dermatology problem 198 Other inflammatory condition of skin 
199 Chronic ulcer of skin 
200 Other skin disorders 
Poisoning 241 Poisoning by psychotrophic agents 
242 Poisoning by other medication and drugs 
243 Poisoning by nonmedical substances 
Syncope 245 Syncope 
Other non-cardiac  10 Immunization and screening for infectious disease 
45 Maintenance chemotherapy, radiotherapy 
52 Nutritional deficiencies 
55 Fluid and electrolyte disorders 
56 Cystic fibrosis 
57 Immunity disorder 
120 Hemorrhoids 
121 Other diseases of veins and lymphatics 
167 Nonmalignant breast conditions 
168 Inflammatory disease of female pelvic organs 
169 Endometriosis 
172 Ovarian cyst 
173 Menopausal disorders 
202 Rheumatoid arthritis and related disease 
203 Osteoarthritis 
204 Other non-traumatic joint disorders 
205 Spondylosis; intervertebral disc disorders; other back problems 
206 Osteoporosis 
208 Acquired foot deformities 
209 Other acquired deformities 
210 Systemic lupus erythematosus and connective tissue disorders 
211 Other connective tissue disease 
212 Other bone disease and musculoskeletal deformities 
217 Other congenital anomalies 
237 Complication of device; implant or graft 
238 Complications of surgical procedure or medical care 
240 Burns 
246 Fever of unknown origin 
247 Lymphadenitis 
248 Gangrene 
252 Malaise and fatigue 
253 Allergic reactions 
254 Rehabilitation care; fitting of prostheses; and adjustment of devices 
255 Administrative/social admission 
256 Medical examination/evaluation 
257 Other aftercare 
258 Other screening for suspected conditions (not mental disorders or infectious 
disease) 
259 Residual codes; unclassified 
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Heart failure  108 Congestive heart failure non-hypertensive 
Arrhythmia  106 Cardiac dysrhythmias 
107 Cardiac arrest and ventricular fibrillation 
Conduction disorder  105 Conduction disorders 
Valve disorders  96 Heart valve disorder 
Hyper/hypotension  98 Essential hypertension 
99 Hypertension with complications and secondary hypertension 
183 Hypertension complicating pregnancy; childbirth and the puerperium 
249 Shock 
Pericarditis  97 Peri-, endo- and myocarditis, cardiomyopathy 
Coronary artery disease 
including angina 
101 Coronary atherosclerosis and other heart disease includes angina 
Acute myocardial infarction   100 Acute myocardial infarction 
Others (cardiac)   103 Pulmonary heart disease 
104 Other and ill-defined heart disease 
213 Cardiac and circulatory congenital anomalies 
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Supplementary Table 2: Sensitivity analysis of the subgroup of patients with acute myocardial 
infarction after exclusion of elective cases 
A) Multiple logistic regression to identify independent variables associated with patients who 
discharge against medical advice 
Variables Odds ratio (95%CI) p-value 
Age (per 1 year increment) 0.96 (0.96-0.97) <0.001 
Female 0.60 (0.53-0.67) <0.001 
Primary expected payer vs Medicare  
Medicaid 1.21 (1.03-1.42) 0.019 
Private 
Other 
0.27 (0.23-0.31) 
0.72 (0.58-0.90) 
<0.001 
0.004 
Smoker 1.77 (1.59-1.97) <0.001 
Alcohol misuse 1.28 (1.07-1.53) 0.006 
Drug abuse 1.83 (1.57-2.13) <0.001 
Dyslipidemia 0.61 (0.55-0.67) <0.001 
Diabetes mellitus 1.12 (1.00-1.25) 0.043 
Previous myocardial infarction 1.41 (1.23-1.48) <0.001 
Previous percutaneous coronary 
intervention 
1.55 (1.37-1.76) <0.001 
Previous stroke/TIA 1.27 (1.06-1.51) 0.010 
Peripheral vascular disease 1.23 (1.03-1.46) 0.019 
Chronic lung disease 1.30 (1.15-1.46) <0.001 
Hypothyroidism 0.70 (0.54-0.90) 0.005 
Teaching hospital 0.84 (0.76-0.93) <0.001 
Intravascular ultrasound 0.74 (0.59-0.93) 0.010 
Drug eluting stent 0.64 (0.58-0.70) <0.001 
Acute kidney injury 2.51 (1.53-4.13) <0.001 
Emergency coronary artery bypass graft 0.45 (0.26-0.76) <0.001 
 
B) Multiple logistic regression to determine independent variables associated with readmission 
within 30 days 
Variables Odds ratio (95%CI) p-value 
Discharge against medical advice 1.96 (1.73-2.22) <0.001 
Female 1.29 (1.25-1.33) <0.001 
Primary expected payer vs Medicare  
Medicaid 1.19 (1.12-1.26) <0.001 
Private 0.70 (0.67-0.73) <0.001 
Uninsured 0.75 (0.71-0.80) <0.001 
Other 0.82 (0.76-0.88) <0.001 
Smoker 0.91 (0.89-0.94) <0.001 
Drug abuse 1.30 (1.20-1.40) <0.001 
Dyslipidemia 0.90 (0.87-0.93) <0.001 
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Hypertension 1.09 (1.05-1.13) <0.001 
Diabetes mellitus 1.21 (1.18-1.23) <0.001 
Obesity 0.90 (0.87-0.94) <0.001 
Previous heart failure 0.76 (0.59-0.98) 0.033 
Atrial fibrillation 1.40 (1.39-1.52) <0.001 
Previous transient ischemic attack/stroke 1.19 (1.13-1.26) <0.001 
Peripheral vascular disease 1.21 (1.15-1.27) <0.001 
Chronic lung disease 1.38 (1.32-1.43) <0.001 
Renal failure 1.52 (1.46-1.59) <0.001 
Liver disease 1.30 (1.16-1.45) <0.001 
Fluid and electrolyte disorders 1.21 (1.16-1.26) <0.001 
Anemia 1.36 (1.30-1.43) <0.001 
Cancer 1.54 (1.40-1.70) <0.001 
Depression 1.18 (1.11-1.25) <0.001 
Dementia 1.32 (1.18-1.47) <0.001 
Teaching hospital 0.96 (0.93-0.99) 0.023 
Intra-aortic balloon pump 1.38 (1.03-1.84) 0.031 
Fractional flow reserve 1.14 (1.00-1.30) 0.046 
Drug eluting stent 0.82 (0.79-0.84) <0.001 
Cardiogenic shock 1.10 (1.01-1.20) 0.029 
Emergency coronary artery bypass graft 0.85 (0.73-1.00) 0.047 
 
C) Cause of readmission by discharge against medical advice status 
Cause of readmission Not DAMA (%) DAMA (%) 
Cardiac 49.2 56.6 
Non-cardiac 50.8 43.4 
 
Cause of non-cardiac 
readmission 
Not DAMA (%) DAMA (%) 
Non-specific chest pain 19.6 21.5 
Infections 10.1 11.0 
Respiratory 7.2 8.8 
Neuropsychiatric 2.2 6.1 
Gastrointestinal 11.1 6.1 
Peripheral vascular disease 4.5 3.9 
Renal failure 3.2 5.5 
Bleeding 5.3 2.2 
TIA/stroke 4.9 3.3 
Hematological/neoplasm 2.4 1.1 
 
Cause of cardiac readmission Not DAMA (%) DAMA (%) 
Diagnosis of acute myocardial 
infarction 
14.7 47.5 
Coronary artery disease 41.7 25.0 
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including angina 
Heart failure 12.5 17.8 
Arrhythmias 13.0 7.6 
Pericarditis 1.1 0.8 
Valve disorders 0.8 0.4 
Conduction disorders 0.9 0.0 
Hyper/hypotension 0.0 0.0 
Other cardiac 15.2 0.8 
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Supplementary Table 3: Causes of psychiatric readmissions 
Causes of psychiatric readmissions Not DAMA (%) DAMA (%) 
Depression, bipolar and mood disorder 24.3 43.3 
Paranoid schizophrenia, schizoaffective disorder and psychosis 7.5 16.7 
Alcohol intoxication, withdrawal and related disease 8.3 10.0 
Illicit drug related illness (opioid, cocaine, etc). 8.3 10.0 
Anxiety and panic disorder 16.0 6.7 
Epilepsy, convulsions and seizure 13.0 0.0 
Headache and migraine 5.5 0.0 
Dementia 2.6 0.0 
Stress 0.8 0.0 
Other 13.6 13.3 
 
 
